Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss

GLP-1 Medications

Amazon Rolls Out Nationwide GLP-1 Care Program Through One Medical

The move signals retailers are reshaping access to obesity drugs.

GLP-1 Pills Accelerate into U.S. Care with Amazon Rollout and New Evidence on Use and Response

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

FDA Clears 7.2‑mg Wegovy as India Enters Generic Semaglutide Era

Novo Nordisk Strikes Deal With Hims & Hers to Sell Wegovy and Ozempic, Drops Lawsuit

Novo Nordisk Sues Hims & Hers to Halt Compounded Wegovy Copycats

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Novo Nordisk Lowers Wegovy and Ozempic Cash Price to $349 and Unveils $199 Starter Offer

Oval Office Event Pauses as Pharma Representative Faints During Trump’s GLP-1 Pricing Announcement

U.S. Obesity Rate Drops to 37% as GLP-1 Use Surges, Gallup Finds

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Eli Lilly to Raise UK Mounjaro Prices by Up to 170% in September

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research